Deepak Lodha: PT and aPTT Mixing Study is a Key Tool in Coagulation Diagnosis
Deepak Lodha, Lab Technician at Dr Lal PathLabs, shared a post on LinkedIn:
“PT and aPTT Mixing Study – A Key Tool in Coagulation Diagnosis
In routine laboratory practice, prolonged PT or aPTT often creates diagnostic confusion.
Is it a factor deficiency or the presence of a circulating inhibitor?
This is where the Mixing Study becomes essential.
By mixing patient plasma with normal plasma (1:1) and reassessing clotting time, we can identify the underlying cause:
- Correction of PT/aPTT suggests factor deficiency. Seen in conditions like Vitamin K deficiency, liver disease, Hemophilia, or early DIC
- No correction ndicates presence of inhibitor, such as Lupus anticoagulant, Factor VIII inhibitor, or heparin effect
Incubated mixing study further helps detect time-dependent inhibitors, which may not be evident immediately.
This simple yet powerful test:
- Improves diagnostic accuracy
- Guides appropriate treatment (factor replacement vs inhibitor management)
- Prevents unnecessary transfusions
In coagulation testing, correct interpretation is just as important as performing the test. Always correlate with clinical findings and additional tests like TT, fibrinogen, and D-dimer.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic